세계의 인공호흡기 시장 : 모빌리티별, 종류별, 인터페이스별, 모드별, 최종사용자별, 지역별 평가, 기회와 예측(2016-2030년)

Global ventilator market was valued at USD 4.35 billion in 2022, expected to reach USD 6.07 billion in 2030 with a CAGR of 4.26% for the forecast period between 2023 and 2030F. The global market has evolved in recent years owing to technological advances in ventilator technology and improved sensor technologies utilized in ventilators. With increasing hospitalization due to COVID-19 and other chronic diseases in recent years, the demand for ventilators has increased significantly, further boosting the global ventilator market. The increased demand for ventilators is pushing the market players to cater to the unmet needs. Several nations have an addressable gap between supply and demand that can serve as an opportunity for market players. Thus, the global ventilator market is growing due to increasing ICU admissions, increased chronic disease prevalence, advancements in products to enhance effectiveness and patient compliance, and so on. Moreover, the COVID-19 pandemic exposed the shortcomings of the critical care system. This led governments to focus more on developing and evolving the critical care settings in hospitals to bridge the demand and supply gap. A notable surge in ventilator installations has been observed during the pandemic period. Lack of trained professionals and complications associated with ventilators are the challenges that can hinder the market.

Increasing ICU Admissions Due to COVID-19 and Growing Burden of Chronic Disease

The global ventilator market is undergoing a significant transformation due to the simultaneous increase in ICU admissions and the growing burden of chronic diseases. The surge in ICU admissions, especially during the COVID-19 pandemic, has placed immense pressure on healthcare systems worldwide. This increased demand for ventilators as a critical tool in managing severe respiratory conditions led to a substantial increase in production and distribution. The rising prevalence of chronic diseases, such as chronic obstructive pulmonary disease (COPD) and cardiovascular disease, is contributing to a consistent requirement for ventilatory support in non-ICU settings. As a result, the global ventilator market is expanding to meet these evolving healthcare needs, with technological advancements and an increased focus on developing more accessible and advanced ventilator solutions. This dual impact of surging ICU admissions and the increasing chronic disease burden is reshaping the ventilator market, making it an important sector for innovation and investment in the healthcare industry.

Introduction Of Cutting-Edge Technologies in Ventilators

Technological advancements are playing a significant role in driving the global ventilator market. These innovations are not only enhancing the performance and capabilities of ventilators but also addressing critical issues related to patient comfort, ease of use, and remote monitoring. Smart ventilators equipped with sophisticated sensors and connectivity features are becoming increasingly prevalent, allowing healthcare providers to monitor patients' respiratory status and adjust settings remotely, thereby improving patient care and reducing the workload on healthcare staff. Furthermore, the integration of artificial intelligence and machine learning enables ventilators to adapt to real-time to fulfil individual patient needs, optimizing treatment and reducing the risk of complications.

Additionally, advancements in materials and design are making ventilators more compact and portable, facilitating their use in various healthcare settings. These technological advancements are increasing the efficiency of ventilators and expanding their application. Pune's medical device company, Noccarc, launched Noccarc V730i Smart ICU Ventilator in June 2023. The Noccarc V730i, uses smart technology to enhance critical care. This ventilator can access cloud capabilities through its internet connectivity, enabling remote software updates.

Government Initiatives

Governments around the globe have provided financial incentives and regulatory support to encourage research, development, and manufacturing of ventilators, leading to innovations in design, functionality, and accessibility. Ventilators are an essential part of critical healthcare systems and several government initiatives in different countries have provided cost-efficient and effective solutions to the public. During the COVID-19 pandemic, the demand for ventilators in hospitals grew exponentially, which led the governments to take immediate action to facilitate critical care management of patients. Governments provided financial incentives and regulatory support to encourage research, development, and manufacturing of ventilators. The government of the United States, under the Defense Production Act, paid Philips USD 646.7 million to deliver 2,500 ventilators to the Strategic National Stockpile by the end of May 2020. This was part of a larger initiative aiming to provide 43,000 ventilators by the end of 2020. In India, the PM CARES fund allocated USD 280 million to supply 50,000 "made in India" ventilators to government-run COVID-19 hospitals in all states and union territories.

Impact of COVID-19

The global ventilator market experienced a significant impact due to the COVID-19 pandemic. With the rapid and widespread transmission of the virus, the need for ventilators surged dramatically, particularly during the initial stages of the pandemic when hospitals faced unprecedented patient loads. This sudden surge in demand led to shortages in many regions, prompting governments and healthcare providers to bolster their ventilator supplies. Italy witnessed a significant growth of 66.42% in the number of ICU units. There were 5179 ICU units before the pandemic, reaching 8619 post COVID-19 pandemic.

Consequently, there was a significant increase in the production and procurement of ventilators worldwide, with numerous companies and industries pivoting to address the urgent need. The pandemic also accelerated innovations in ventilator technology, focusing on improved patient monitoring and portability. While the initial demand has subsided, the pandemic highlighted the importance of ventilator infrastructure and readiness for future health crisis.

Portable Ventilators will Grow at a Faster Pace

The future of portable ventilators will witness rapid growth in the forecasted period. Several factors drive this surge in demand for portable ventilators. Firstly, technological advancements have made it possible to develop compact, lightweight, and battery-powered ventilators that offer mobility and flexibility, allowing patients greater freedom and independence. As healthcare trends increasingly shift towards home-based and outpatient care, the need for portable ventilators will keep growing by allowing patients to manage their respiratory conditions in familiar and comfortable settings. Additionally, the ongoing emphasis on telemedicine and remote monitoring further underscores the importance of portable ventilators, which healthcare professionals can remotely control and monitor.

In October 2021, Movair announced the commercial launch of Luisa Life Supporting Ventilator with high-flow oxygen therapy in the United States. Luisa is equipped with a 10-inch display that can be rotated, along with adaptable connectivity features, allowing patients to seamlessly incorporate the ventilator into their everyday routines, including aligning it with their preferred side of the bed for sleeping. Additionally, Luisa offers multi-language programming capabilities, guaranteeing that a wide array of patients, families, and caregivers can easily understand the alarm notifications.

Key Players Landscape and Outlook

The global ventilator market features a landscape dominated by key players such as Koninklijke Philips N.V., Getinge AB, ResMed, Medtronic, Fisher & Paykel Healthcare Limited, Avasarala Technologies Limited, Allied Healthcare Products, Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd and many others. Companies are introducing ventilators with additional features and organizations are also focusing on portable ventilators. Market players are developing partnerships to reach emerging and underdeveloped economies.

United Kingdom based manufacturer of anesthesia equipment OES Medical launched its new mains-powered ICU ventilator to support hospitals in managing oxygen demand at Arab Health 2022. The Gemini-G100, is an electrically operated piston ICU ventilator equipped with an integrated oxygen concentrator, tailored for intensive care applications. This device is specifically engineered for use in situations where a readily available supply of high-pressure oxygen gas is limited. The Gemini-G100 doesn't impose any oxygen supply burden on the hospital as it only requires electrical power. This feature greatly benefits hospitals by reducing their dependency on oxygen deliveries, particularly during periods of heightened demand.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of COVID-19 on Global Ventilator Market

4. Executive Summary

5. Global Ventilator Market Outlook, 2016-2030F

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
  • 5.1.2. By Volume
• 5.2. By Mobility
  • 5.2.1. Intensive Care Ventilators
    • 5.2.1.1. High-End ICU Ventilators
    • 5.2.1.2. Mid-End ICU Ventilators
    • 5.2.1.3. Basic ICU Ventilators
  • 5.2.2. Portable/Transportable Ventilators
• 5.3. By Type
  • 5.3.1. Adult Ventilators
  • 5.3.2. Pediatric Ventilators
  • 5.3.3. Neonatal/Infant Ventilators
• 5.4. By Interface
  • 5.4.1. Invasive Ventilators
  • 5.4.2. Non-Invasive Ventilators
• 5.5. By Mode
  • 5.5.1. Combined Mode Ventilators
  • 5.5.2. Volume Mode Ventilators
  • 5.5.3. Pressure Mode Ventilators
  • 5.5.4. Others
• 5.6. By End-user
  • 5.6.1. Hospitals
  • 5.6.2. Ambulatory Care Centers
  • 5.6.3. Clinics
  • 5.6.4. Home Care Settings
  • 5.6.5. Others
• 5.7. By Region
  • 5.7.1. North America
  • 5.7.2. Europe
  • 5.7.3. South America
  • 5.7.4. Asia-Pacific
  • 5.7.5. Middle East and Africa
• 5.7 By Company Market Share (%), 2022

6. Global Ventilator Market Outlook, 2016-2030F

• 6.1. North America*
  • 6.1.1. By Mobility
    • 6.1.1.1. Intensive Care Ventilators
    • 6.1.1.1.1. High-End ICU Ventilators
    • 6.1.1.1.2. Mid-End ICU Ventilators
    • 6.1.1.1.3. Basic ICU Ventilators
    • 6.1.1.2. Portable/Transportable Ventilators
  • 6.1.2. By Type
    • 6.1.2.1. Adult Ventilators
    • 6.1.2.2. Pediatric Ventilators
    • 6.1.2.3. Neonatal/Infant Ventilators
  • 6.1.3. By Interface
    • 6.1.3.1. Invasive Ventilators
    • 6.1.3.2. Non-Invasive Ventilators
  • 6.1.4. By Mode
    • 6.1.4.1. Combined Mode Ventilators
    • 6.1.4.2. Volume Mode Ventilators
    • 6.1.4.3. Pressure Mode Ventilators
    • 6.1.4.4. Others
  • 6.1.5. By End-user
    • 6.1.5.1. Hospitals
    • 6.1.5.2. Ambulatory Care Centers
    • 6.1.5.3. Clinics
    • 6.1.5.4. Home Care Settings
    • 6.1.5.5. Others
  • 6.1.6. United States*
    • 6.1.6.1. By Mobility
    • 6.1.6.1.1. Intensive Care Ventilators
    • 6.1.6.1.1.1. High-End ICU Ventilators
    • 6.1.6.1.1.2. Mid-End ICU Ventilators
    • 6.1.6.1.1.3. Basic ICU Ventilators
    • 6.1.6.1.2. Portable/Transportable Ventilators
    • 6.1.6.2. By Type
    • 6.1.6.2.1. Adult Ventilators
    • 6.1.6.2.2. Pediatric Ventilators
    • 6.1.6.2.3. Neonatal/Infant Ventilators
    • 6.1.6.3. By Interface
    • 6.1.6.3.1. Invasive Ventilators
    • 6.1.6.3.2. Non-Invasive Ventilators
    • 6.1.6.4. By Mode
    • 6.1.6.4.1. Combined Mode Ventilators
    • 6.1.6.4.2. Volume Mode Ventilators
    • 6.1.6.4.3. Pressure Mode Ventilators
    • 6.1.6.4.4. Others
    • 6.1.6.5. By End-user
    • 6.1.6.5.1. Hospitals
    • 6.1.6.5.2. Ambulatory Care Centers
    • 6.1.6.5.3. Clinics
    • 6.1.6.5.4. Home Care Settings
    • 6.1.6.5.5. Others
  • 6.1.7. Canada
  • 6.1.8. Mexico

All segments will be provided for all regions and countries covered:

• 6.2. Europe
  • 6.2.1. Germany
  • 6.2.2. France
  • 6.2.3. Italy
  • 6.2.4. United Kingdom
  • 6.2.5. Russia
  • 6.2.6. Netherlands
  • 6.2.7. Spain
  • 6.2.8. Turkey
  • 6.2.9. Poland
• 6.3. South America
  • 6.3.1. Brazil
  • 6.3.2. Argentina
• 6.4. Asia-Pacific
  • 6.4.1. India
  • 6.4.2. China
  • 6.4.3. Japan
  • 6.4.4. Australia
  • 6.4.5. Vietnam
  • 6.4.6. South Korea
  • 6.4.7. Indonesia
  • 6.4.8. Philippines
• 6.5. Middle East & Africa
  • 6.5.1. Saudi Arabia
  • 6.5.2. UAE
  • 6.5.3. South Africa

7. Market Mapping, 2022

• 7.1. By Mobility
• 7.2. By Type
• 7.3. By Interface
• 7.4. By Mode
• 7.5. By End-user
• 7.6. By Region

8. Macro Environment and Industry Structure

• 8.1. Supply Demand Analysis
• 8.2. Import Export Analysis - Volume and Value
• 8.3. Supply/Value Chain Analysis
• 8.4. PESTEL Analysis
  • 8.4.1. Political Factors
  • 8.4.2. Economic System
  • 8.4.3. Social Implications
  • 8.4.4. Technological Advancements
  • 8.4.5. Environmental Impacts
  • 8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 8.5. Porter's Five Forces Analysis
  • 8.5.1. Supplier Power
  • 8.5.2. Buyer Power
  • 8.5.3. Substitution Threat
  • 8.5.4. Threat from New Entrant
  • 8.5.5. Competitive Rivalry

9. Market Dynamics

• 9.1. Growth Drivers
• 9.2. Growth Inhibitors (Challenges, Restraints)

10. Regulatory Framework and Innovation

• 10.1. Clinical Trials
• 10.2. Patent Landscape
• 10.3. Regulatory Approvals
• 10.4. Innovations/Emerging Technologies

11. Key Players Landscape

• 11.1. Competition Matrix of Top Five Market Leaders
• 11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2022)
• 11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 11.4. SWOT Analysis (For Five Market Players)
• 11.5. Patent Analysis (If Applicable)

12. Pricing Analysis

13. Case Studies

14. Key Players Outlook

• 14.1. Koninklijke Philips N.V.
  • 14.1.1. Company Details
  • 14.1.2. Key Management Personnel
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As reported)
  • 14.1.5. Key Market Focus & Geographical Presence
  • 14.1.6. Recent Developments
• 14.2. Getinge AB
• 14.3. ResMed
• 14.4. Medtronic
• 14.5. Fisher & Paykel Healthcare Limited
• 14.6. Avasarala Technologies Limited
• 14.7. Allied Healthcare Products, Inc.
• 14.8. Shenzhen Mindray Bio-Medical Electronics Co., Ltd,
• 14.9. Dragerwerk AG & CO. KGAA
• 14.10. Nihon Kohden Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

15. Strategic Recommendations

16. About Us & Disclaimer